Logo
    Search

    #33 - Rudy Leibel, M.D.: Finding the obesity gene and discovering leptin

    enDecember 17, 2018

    Podcast Summary

    • The Discovery of Leptin: Unraveling the Genetics of Obesity and DiabetesCollaboration and shared passion in science can lead to significant breakthroughs, as seen in the discovery of leptin and its impact on our understanding of obesity and diabetes.

      The discovery of leptin, with Rudy playing a critical role, was a significant scientific achievement in the field of type 2 diabetes and obesity. While the discussion delves into technical and complex scientific concepts, it provides valuable insights into the genetics of obesity, energy expenditure measurements, and the role of insulin resistance. Rudy and Peter's long-standing friendship and shared passion for science create an engaging and informative dialogue. It is clear that Rudy's expertise and contributions have had a substantial impact on our understanding of obesity and diabetes. The conversation also highlights the importance of collaboration and the joy of sharing intellectual discoveries over good food and drinks.

    • Investigating the biology of body weight regulation and its connection to obesity and diabetes.Rudy Leibel's research on obesity has provided insights into the role of genetics, adipose tissue, and stem cells in body weight regulation, contributing to a better understanding of the relationship between obesity and diabetes.

      Rudy Leibel is a renowned researcher and physician who has dedicated his career to studying the biology of body weight regulation in animals and humans. He has focused on the clinical problem of obesity for over 30 years and has explored various approaches, including studying human adipose tissue, investigating the genetics of obesity, and conducting studies in mice. Recently, he has also delved into the use of stem cells to understand brain cells and pancreatic cells related to body weight regulation and insulin production. Leibel's interest in the hypothalamus, a small organ situated above the pituitary gland, stems from his early exposure to its importance in physiology during his time at the Walter Reed Army Institute of Research. Overall, his studies have led to a deeper understanding of the interconnectedness of obesity and diabetes.

    • The critical role of the hypothalamus in regulating bodily functions and behaviors.Understanding the role of the hypothalamus in regulating appetite and metabolism is crucial for maintaining a healthy balance and addressing obesity and related disorders. Further research in this area is needed.

      The hypothalamus, a critical part of the brain, plays a vital role in regulating various bodily functions and behaviors, including appetite and metabolism. Both Rudy Leibel and Peter Attia emphasize the importance of this brain region. Leibel explains that the hypothalamus and the part of the brain regulating respiration are crucial for survival. This highlights the significance of maintaining a healthy balance in these brain areas. Additionally, the conversation sheds light on the challenges in understanding the complexity of obesity, as evidenced by Leibel's encounter with an obese child and his realization of the limited knowledge and treatments available at that time. Ultimately, the conversation emphasizes the need for further research and understanding of the brain's role in obesity and related disorders.

    • The Broad Perspective of Medical EducationMedical education offers physicians the ability to examine problems from various levels and make significant contributions to improving human health through research and mentorship.

      A medical education provides a unique opportunity for physicians to have a broad perspective on the human condition. It allows them to examine problems from psychological to biological and even social levels. The ability to pause, reflect, and seek answers to clinical situations is a common trait among great physician scientists. In the case of Rudy Leibel, a chance encounter altered the entire course of his career, leading to remarkable research and discoveries. Additionally, mentorship plays a crucial role in the success of scientists. Overall, medicine presents a privilege that can be leveraged to make significant contributions to the understanding and improvement of human health.

    • The Evolution of Understanding Adipose TissueQuestioning existing beliefs and exploring new avenues of scientific inquiry led to the discovery of important hormonal functions in fat cells, highlighting the importance of continuous exploration in scientific research.

      The understanding of adipose tissue, or fat, has evolved over time. During the 1970s, adipose tissue was primarily seen as a passive storage depot for fat. However, scientists like Rudy Leibel began to question this view and explore the possibility that fat cells could have important hormonal functions. This shift in thinking was prompted by observations of how fat mass affected insulin levels in the body. It was not until later, through the work of researchers like Douglas Coleman and the study of mice mutations, that the hormone leptin was discovered as a significant factor secreted by fat cells. This conversation highlights the importance of questioning existing beliefs and continuously exploring new avenues of scientific inquiry.

    • The role of hormones in controlling body weightHormones play a vital role in regulating body weight, as demonstrated through experiments on mice with obesity and diabetes mutations.

      The OB mouse, which is prone to obesity due to excessive food intake, was found to be missing a specific circulating hormone that regulates body weight. This hormone, referred to as the ligand, is produced by the wild type mouse. Additionally, another mutation called the diabetes mouse, which also displayed overeating but had a tendency to develop diabetes, was found to be missing the ability to respond to the ligand. Through parabiosis experiments, it was discovered that when the OB mouse was connected to a wild type mouse, it corrected its excessive appetite and began to lose weight. On the other hand, when the wild type mouse was connected to the diabetes mouse, it stopped eating and eventually died of starvation. These findings highlight the importance of hormonal regulation in controlling body weight.

    • Signals from adipose tissue control the expansion of fat cells in obese individualsSignals released by fat cells recruit more fat cells, leading to hyperplastic adipose tissue in obese individuals. This knowledge could lead to new approaches in managing obesity.

      The expansion of fat cells and the generation of new fat cells in obese individuals is regulated by signals from adipose tissue. This discovery was made in the late 1970s by researchers like Jules Hirsch and Rudy Leibel. They found that as fat cells reach a maximum size, they release signals that recruit more fat cells, leading to hyperplastic adipose tissue in very obese individuals. The adipose tissue, which contains organelles like any other cell, plays a crucial role in this process. Additionally, experiments conducted on rats, both lean and obese, showed that the regeneration of fat cells occurred even in lean animals. This knowledge contributes to our understanding of obesity and could potentially lead to new approaches in managing it.

    • Models of Obesity and the Role of Lipoprotein LipaseUnderstanding the mechanisms behind obesity is challenging due to conflicting models such as the pool model and the push model. The role of lipoprotein lipase (LPL) in obesity is also complex, with evidence suggesting it may not be necessary for normal adipose tissue.

      There are different models for understanding the mechanisms behind obesity. One model suggests that the adipose tissue acts like a vacuum cleaner, sucking up circulating fat and storing it, leading to obesity. This is known as the pool model. Another model, known as the push model, suggests that the brain itself is pushing the substrate into the fat cells, causing them to be filled up from the outside. Both models have evidence to support them, making it a challenge to determine the primary mechanisms for controlling body weight. Additionally, the conversation highlights the significance of lipoprotein lipase (LPL) in obesity. However, individuals who are completely deficient in LPL can have normal adipose tissue, suggesting that LPL may not be absolutely necessary.

    • Early techniques for mapping obesity genes were time-consuming and complex.Early experiments using genetic techniques laid the foundation for understanding obesity genetics, despite being limited in their ability to provide quantitative assessments.

      Early experiments in mapping and identifying obesity genes required complex techniques and took a significant amount of time compared to modern methods. Scientists like Rudy Leibel used techniques such as genetic crossing and Southern blotting to identify genetic markers and track obesity-related genes in rats. By correlating the presence of these markers with the obesity levels of the animals, they could narrow down the region of the genome where the obesity gene resided. This process provided a qualitative assessment of obesity rather than a quantitative one. While the resolution was limited to identifying the gene's location on a specific region of the chromosome, these experiments laid the foundation for further research and understanding of obesity genetics.

    • Exploring the OB Gene and Its Role in Body Weight RegulationThe OB gene, discovered through extensive research on rats and humans, is a significant player in controlling body weight, offering valuable insights into the genetics of obesity.

      Rudy Leibel and his team conducted extensive research on both rats and humans to understand the regulation of body weight and energy metabolism. Through their studies, they discovered the existence of a single gene, known as the OB gene, which played a significant role in controlling body weight. This finding was supported by the breeding patterns observed in both rats and mice. By mapping the location of the OB gene in different species, they were able to rule out other potential genes, such as the lipoprotein lipase gene, that could have been responsible for obesity-related traits. This research provided valuable insights into the genetics behind obesity and laid the foundation for further discoveries in the field.

    • Cloning genes in the mid-1980s: Challenges, perseverance, and trial and errorThe process of cloning genes in the mid-1980s required patience, perseverance, and precise manipulation of chromosomes, despite the lack of advanced tools.

      The process of cloning genes in the mid-1980s was challenging and required a lot of perseverance and trial and error. The researchers, Rudy Leibel and Jeff Friedman, were not experts in molecular genetics but trained themselves to do the work. They faced similar difficulties as other scientists who were trying to clone genes for diseases like Huntington's disease and cystic fibrosis. The process involved using techniques like southern blotting and using markers to locate specific genes on chromosomes. The researchers had to carefully examine obese mice to determine their genotype and use their DNA to create a map of the gene's location. Patience and precise manipulation of chromosomes were crucial for the success of this project at that time when advanced tools were not available.

    • Gene location and relationship not necessary for ligand receptor functionThrough careful analysis of gene transcripts and comparing mutated animals to normal ones, researchers discovered the OB gene's role in weight regulation, despite its location on different chromosomes in mice and humans.

      The function of ligand receptor genes does not require them to be on the same chromosome or in close proximity to each other. The researchers knew that the ligand receptor genes were not on the same chromosome, and it was confirmed that there is no relationship between them. The critical breakthrough in cloning the gene involved creating a fine map of the region and analyzing the transcripts being read off of the DNA. By comparing transcripts from mutated animals to normal ones, they discovered the gene responsible for the phenotype. This gene, known as the OB gene, was found to be predominantly expressed in adipose tissue, aligning with previous experiments that implicated adipose tissue in weight regulation. The OB gene is located on chromosome 6 in mice and chromosome 7 in humans.

    • The Role of Leptin in Obesity Research.Leptin plays a crucial role in regulating body weight, signaling the brain about available energy and potentially preventing pregnancy in certain circumstances.

      The discovery of the OB gene, also known as leptin, and its role in regulating body weight was a significant breakthrough in obesity research. It was found that the fat cell secretes leptin, and the lack of leptin in the OB mouse can be cured by introducing it. However, the DB mouse, which produces excessive amounts of leptin, cannot be fixed in the same way. This demonstrates the importance of understanding both ligand and receptor deficiencies in genetic disorders. The identification of the DB gene and its mapping to chromosome 4 in the mouse further validated the role of leptin in obesity. Additionally, it was realized that leptin primarily serves as a signal to the brain, indicating the availability of energy for survival and reproductive processes. Nature evolved leptin to regulate food intake and potentially prevent pregnancy under certain circumstances.

    • Challenges in Regulation and Treatment of Obesity Associated with LeptinLeptin therapy is effective for individuals with OB gene mutations but not for those with leptin receptor mutations, highlighting the complexity of regulating appetite and developing interventions for obesity.

      There are individuals with mutations in the OB gene and leptin receptor mutations who experience obesity due to disruptions in the regulation of leptin, a hormone that signals satiety. While leptin supplementation has proven to be an effective treatment for those with OB gene mutations, individuals with leptin receptor mutations do not respond to leptin therapy. Currently, there is no effective intervention for this group, although drugs targeting the melanocortin 4 receptor are being developed as a potential solution. Additionally, Amgen's attempt to develop leptin as an obesity drug was not successful, as only individuals with leptin deficiency showed significant improvement with increased leptin levels. Overall, leptin regulation is complex and not easily manipulated to control appetite in every individual.

    • Prader Willy: A Genetic Disorder with Distinct PhenotypePrader Willy is a genetic disorder characterized by poor growth, feeding difficulties, and extreme hunger. Close monitoring of food access and parental attention are crucial in managing the condition.

      Prader Willy is a genetic disorder characterized by a large deletion in a region of chromosome 15. In this region, the paternal genes are deleted, while the maternal genes are silenced. Individuals with Prader Willy have a distinct phenotype, including poor growth, feeding difficulties, and hyperphagia (extreme hunger). They often require close monitoring of their food access, and in some cases, food needs to be locked away to prevent overeating. However, with careful management, the severity of the disease can be reduced. Treatments such as growth hormone therapy can help alleviate some of the endocrine disturbances associated with the disorder. While clinical trials are necessary to investigate potential interventions, managing the condition with parental attention is crucial.

    • Exploring the Potential Benefits of a Ketogenic Diet for Prader-Willi Syndrome and Its Link to HyperinsulinemiaA ketogenic diet shows promise in improving cognitive development and managing Prader-Willi syndrome, while hyperinsulinemia and the activity of proconvertase 1 may play a role in the condition. Understanding Prader-Willi syndrome can also inform obesity treatment.

      A ketogenic diet may have positive effects on children with Prader-Willi syndrome, correcting their phenotype and improving cognitive development. This anecdotal evidence from a support group of parents highlights the potential benefits of this dietary approach for managing the condition, although controlled data is still needed. Additionally, the conversation discusses the hyperinsulinemia observed in Prader-Willi patients and its potential link to the deficiency or under activity of an enzyme called proconvertase 1. This enzyme plays a crucial role in processing hormones, including insulin. If this theory proves to be true, increasing the activity of proconvertase 1 could potentially alleviate some of the phenotypes associated with Prader-Willi syndrome. Furthermore, the conversation raises questions about how insights gained from studying Prader-Willi syndrome can contribute to our understanding and treatment of obesity, a widespread issue affecting a significant portion of the population. Research suggests that weight reduction often leads to a disproportional decrease in energy expenditure, primarily driven by a reduction in the energy cost of low levels of physical activity. This reduction may be influenced by low levels of leptin, a hormone associated with body fat.

    • Restoring Energy Expenditure with Leptin InjectionInjecting leptin into weight-reduced individuals can increase their energy expenditure, primarily in skeletal muscle, without the need to regain previous body weight.

      Injecting leptin into weight-reduced individuals can restore their energy expenditure to pre-weight loss levels, even without returning to their previous body weight. This intervention, conducted with low doses of leptin, resulted in an increase of 2 to 300 Kcal per day in energy expenditure. Furthermore, it was found that this effect primarily occurs in skeletal muscle, which becomes less efficient after leptin administration. The conversation also touched upon two methods of measuring energy expenditure - indirect calorimetry and doubly labeled water. Indirect calorimetry involves measuring the rate of oxygen consumption and carbon dioxide production, while metabolic chambers allow for long-term measurements over several days.

    • The Challenges and Engineering of Metabolic Chambers and the Use of Doubly Labeled Water in Energy Expenditure Measurement.Metabolic chambers are costly and require careful attention to leaks and airflow, while the doubly labeled water technique provides a longer data collection period for assessing energy expenditure.

      The construction and maintenance of Metabolic Chambers require a substantial amount of money, attention, and expertise. These chambers, although fun and appealing for the whole family, are expensive and need careful consideration of factors like leaks and airflow. The engineering involved is remarkable, but any mishaps can be challenging to identify and rectify. Additionally, the conversation highlights the use of doubly labeled water as a technique for measuring energy expenditure. This method involves analyzing the concentration of isotopes in urine and exhaled air to calculate carbon dioxide production. While both methods have their limitations, the doubly labeled water technique provides a more extended period for data collection, allowing researchers to assess energy expenditure over days or even weeks.

    • Understanding the Complexity of Appetite RegulationAppetite regulation involves various central and peripheral mechanisms, including hormones and neural signals, emphasizing the need for comprehensive understanding of its multifaceted nature for overall well-being.

      Appetite regulation is a complex and multi-faceted process involving both central and peripheral mechanisms in the body. While the central nervous system, particularly the hypothalamus, plays a significant role in receiving signals related to food intake and energy expenditure, it is not the sole determinant of appetite. Other organs and tissues, such as adipose tissue, the gastrointestinal tract, and neural signals, also contribute to appetite regulation. It is now evident that there are numerous hormones and neural inputs originating from these peripheral sources that interact with the brain to influence both conscious and unconscious responses related to food consumption and body weight regulation. This intricate system highlights the importance of understanding the multifaceted nature of appetite regulation for overall survival and well-being.

    • The complexities of body weight regulation and the impact of environmental factors and genetics.Environmental factors, genetics, and the availability of high-calorie foods contribute to the challenges in regulating body weight. Epigenetic implications and critical periods of development play a role in maintaining higher body weights.

      Body weight regulation is a complex process influenced by various factors, including our environment and genetic predispositions. The frontal cortex plays a role in decision-making related to body weight, while bacteria in the colon also produce molecules that can impact regulation. However, our current environment, with its abundance of easily accessible high-calorie foods, poses challenges to this system that was not designed for such conditions. While obesity rates have shown some signs of slowing down or leveling off, they are still on the rise, albeit at a slower pace. There may be epigenetic implications as well, with early exposure to an obesogenic environment potentially affecting future generations. Understanding critical periods of development and the consequences of manipulation can provide insights into the maintenance of higher body weights.

    • Maternal factors and offspring weight: Understanding the long-term effectsEarly manipulation of a pregnant individual's diet or endocrine system can impact the weight and health of their offspring, emphasizing the need to recognize the influence of maternal factors on future child health.

      Early manipulations in a pregnant animal or human's diet or endocrine system can potentially lead to higher body weight in the offspring. Research suggests that manipulating the metabolism of a pregnant individual can have consequences on the developing brain and physiology of the fetus. There is evidence that obesity in pregnant women increases the risk of obesity in their children. Additionally, the timing of nutrient or insulin exposure during pregnancy, specifically during critical windows of islet cell formation, may have a more profound effect on the offspring's weight. These effects appear to be long-lasting and may not be reversible even if the environment changes. Overall, this highlights the importance of understanding the impact of maternal factors on the future health of offspring.

    • The impact of diet composition on body weight and the effectiveness of low carb diets for weight loss.The composition of a person's diet plays a significant role in their body weight, and low carbohydrate diets can be effective for weight loss due to reduced hunger and potential activation of the body's internal calorie reserves. However, managing hunger can be difficult in sustainable weight loss.

      The composition of a person's diet can have a significant impact on their body weight. Diet composition affects the hedonic aspects of food, influencing the individual's desire to eat and their drive to ingest specific types of food. Different individuals have varying sensitivities to different diet compositions, with some responding well to high carb diets and others to low carb diets. The effectiveness of low carbohydrate diets for weight loss may be attributed to a combination of factors, including reduced hunger, decreased diversity or palatability of the food, and the potential activation of the body's internal calorie reserves. While the theory of less palatable food leading to reduced intake is not entirely convincing, it is clear that hunger can be a challenging and unsustainable aspect of weight loss.

    • The complexity of obesity and the varying effectiveness of low carbohydrate diets in weight loss.Not all diets work for everyone in treating obesity, and it's crucial to maintain a negative energy balance to lose weight, but sustainable strategies are necessary for long-term success.

      The challenge of obesity is complex and not everyone responds to the same treatment. While low carbohydrate diets have shown success for some, they may not work for everybody. The composition of the diet can influence aspects of ingestive behavior and may have metabolic consequences on the drive to eat. It is important for individuals to be in negative energy balance, consuming fewer calories than they expend, in order to lose weight. However, asking someone to be constantly hungry is not sustainable. Low carbohydrate diets seem to be more satiating, but whether this is due to their composition or increased self-control is still unclear. The field of body weight regulation and energy expenditure has expanded beyond the hypothalamus, revealing new aspects of the central nervous system's impact on regulation.

    • Unraveling the Genetic Factors of Obesity and OvereatingThe FTO gene plays a significant role in obesity, but its exact impact on food intake is still unclear. Identifying the mechanisms involved can help prevent and manage obesity through effective interventions.

      There is still a lot to learn about the genetic factors influencing obesity and overeating. While the FTO gene has been identified as having the strongest genetic signal for obesity, the mechanism by which it affects food intake is still unknown. Some researchers believe it may be related to the browning of adipose tissue, while others suggest it affects central nervous system circuits. What is clear is that individuals with the risk variants of this gene tend to eat slightly more and have a preference for higher-fat foods. Understanding the specific mechanisms in the central nervous system would provide valuable insights into preventing and managing obesity. Further research is needed to uncover these mechanisms and develop effective interventions.

    • Genetic Factors and Environmental Triggers Leading to ObesityGenetic variations increase susceptibility to obesity, but they do not directly cause it. By studying the impact of these genes on the nervous system, researchers can gain insights into obesity and potentially develop interventions.

      Obesity is influenced by a combination of genetic factors and environmental triggers. The presence of certain genes, such as those found in the first intron, can increase an individual's susceptibility to obesity. While these genetic variations do not directly cause obesity, they widen the vulnerability to environmental factors that contribute to weight gain. Understanding the structural and functional impacts of these genes on the nervous system can provide valuable insights into the genetic susceptibility to obesity. By studying animals and manipulating these genes, researchers can investigate the effects on food intake and the development of the brain. This knowledge may eventually lead to interventions, such as pharmacological treatments, to combat obesity, although further research is needed in this area.

    • The Impact of Noncoding DNA Sequences on the Central Nervous System and the Potential for Introns to Influence Traits and Conditions.Noncoding DNA sequences called introns can impact the central nervous system, affecting an individual's susceptibility to certain traits or conditions. Removing these introns through CRISPR technology may fix associated phenotypes, indicating their influence occurs at the fertilization level.

      The presence of noncoding DNA sequences, known as introns, can have a structural and consequential impact on the central nervous system. This predisposition can influence the nature and development of the central nervous system, making individuals more or less susceptible to certain traits or conditions. Through experiments using CRISPR technology, it has been observed that editing and removing these introns can fix the phenotypes associated with them. This indicates that the influence of introns transcends development and occurs at the fertilization level. Additionally, the discussion highlights the complexity of insulin resistance and its primary defect in the muscle, where glucose transporters fail to respond to insulin signals. The liver also plays a role in glucose uptake, but the partitioning of glucose between the muscle and liver is determined by other factors aside from capacity.

    • Understanding the Complex Relationships in Insulin ResistanceInsulin resistance in the liver affects lipid synthesis and glycogen release differently based on insulin sensitivity. Obesity and elevated fatty acids may impact muscle glucose homeostasis, emphasizing the importance of comprehending these relationships.

      Insulin resistance in the liver can have different effects on lipid synthesis and glycogen release, depending on the individual's insulin sensitivity. In individuals with issues related to insulin homeostasis, the liver may become resistant to the suppression of gluconeogenesis while maintaining sensitivity to insulin's effects on lipogenesis. The worst outcome occurs when the muscles also become resistant to insulin, leading to a lack of glucose uptake. The debate lies in whether obesity affects adipose tissue, which then affects muscle insulin sensitivity, or if increased lipid content in adipose tissue directly affects muscle glucose homeostasis. It is suggested that high levels of ambient fatty acids may suppress insulin signaling in the muscles. Cahill's 40-day fasted subjects exhibited high free fatty acid levels and low insulin and glucose levels, but their response to glucose may vary depending on the duration of refeeding. Overall, understanding the complex relationships between insulin resistance, lipogenesis, and glycogen release in different tissues is crucial for addressing issues related to insulin homeostasis.

    • Approaching Health and Genetics from Different PerspectivesCollaboration and open-mindedness in scientific research are crucial for unraveling the mechanisms behind complex problems and making valuable discoveries.

      There are different perspectives in approaching complex problems like health and genetics. Rudy Leibel and Peter Attia discuss their differing viewpoints on understanding the impact of environmental triggers on genetic predispositions. While Rudy focuses on identifying the factors that lead to specific outcomes, Peter takes a broader approach, looking for solutions that can benefit a wider range of individuals. They both recognize the importance of unraveling the mechanisms behind these phenomena, whether it be for preventing lung cancer or manipulating biological circuits for overall well-being. This conversation highlights the significance of collaboration and open-mindedness in scientific research, as different approaches can lead to valuable discoveries.

    Recent Episodes from The Peter Attia Drive

    #310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.

    #310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Ted Schaeffer is an internationally recognized urologist specializing in prostate cancer and a returning guest on The Drive. In this episode, Ted provides insights into the role testosterone plays, or doesn't play, in the initiation and progression of prostate cancer. He unpacks the findings and limitations of the recent TRAVERSE trial, exploring the complex relationship between testosterone and prostate cancer. Ted delves into the molecular nature of prostate cancer, explaining the androgen receptor saturation theory and the potential impact of testosterone on cancer growth. He also discusses the use of the Decipher test to predict cancer aggressiveness and guide targeted treatment. Furthermore, Ted shares how he counsels patients regarding testosterone replacement therapy (TRT), including its safe administration in patients with low-grade prostate cancer. Additionally, he highlights advancements in prostate cancer therapies and biomarkers that help develop precise treatment strategies while minimizing the need for broad androgen deprivation therapy.

    We discuss:

    • Background on the TRAVERSE trial: insights into exogenous testosterone and prostate cancer risk [3:00];
    • The androgen receptor saturation theory: how different organs respond to varying levels of testosterone [10:30];
    • The relationship between testosterone levels and prostate cancer aggressiveness: how aggressive prostate tumors have lower androgen receptor activity and rely on different growth mechanisms [16:15];
    • Using the Decipher score to assess prostate cancer aggressiveness and guide personalized treatment strategies [23:45];
    • Considerations for testosterone replacement therapy: how Ted counsels patients, how TRT can be safely administered in patients with low-grade prostate cancer, and more [31:15];
    • Advancements in prostate cancer therapies and PSA as a biomarker for precise treatment decisions, minimizing the need for broad androgen deprivation therapy [38:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 22, 2024

    #309 ‒ AI in medicine: its potential to revolutionize disease prediction, diagnosis, and outcomes, causes for concern in medicine and beyond, and more | Isaac Kohane, M.D., Ph.D.

    #309 ‒ AI in medicine: its potential to revolutionize disease prediction, diagnosis, and outcomes, causes for concern in medicine and beyond, and more | Isaac Kohane, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Isaac "Zak" Kohane, a pioneering physician-scientist and chair of the Department of Biomedical Informatics at Harvard Medical School, has authored numerous papers and influential books on artificial intelligence (AI), including The AI Revolution in Medicine: GPT-4 and Beyond. In this episode, Zak explores the evolution of AI, from its early iterations to the current third generation, illuminating how it is transforming medicine today and unlocking astonishing possibilities for the future. He shares insights from his unconventional journey and early interactions with GPT-4, highlighting significant AI advancements in image-based medical specialties, early disease diagnosis, and the potential for autonomous robotic surgery. He also delves into the ethical concerns and regulatory challenges of AI, its potential to augment clinicians, and the broader implications of AI achieving human-like creativity and expertise.

    We discuss:

    • Zak’s unconventional journey to becoming a pioneering physician-scientist, and his early interactions with GPT-4 [2:15];
    • The evolution of AI from the earliest versions to today’s neural networks, and the shifting definitions of intelligence over time [8:00];
    • How vast data sets, advanced neural networks, and powerful GPU technology have driven AI from its early limitations to achieving remarkable successes in medicine and other fields [19:00];
    • An AI breakthrough in medicine: the ability to accurately recognize retinopathy [29:00];
    • Third generation AI: how improvements in natural language processing significantly advanced AI capabilities [32:00];
    • AI concerns and regulation: misuse by individuals, military applications, displacement of jobs, and potential existential concerns [37:30];
    • How AI is enhancing image-based medical specialties like radiology [49:15];
    • The use of AI by patients and doctors [55:45];
    • The potential for AI to augment clinicians and address physician shortages [1:02:45];
    • The potential for AI to revolutionize early diagnosis and prediction of diseases: Alzheimer’s disease, CVD, autism, and more [1:08:00];
    • The future of AI in healthcare: integration of patient data, improved diagnostics, and the challenges of data accessibility and regulatory compliance [1:17:00];
    • The future of autonomous robotic surgery [1:25:00];
    • AI and the future of mental health care [1:31:30];
    • How AI may transform and disrupt the medical industry: new business models and potential resistance from established medical institutions [1:34:45];
    • Potential positive and negative impacts of AI outside of medicine over the next decade [1:38:30];
    • The implications of AI achieving a level of creativity and expertise comparable to exceptional human talents [1:42:00];
    • Digital immortality and legacy: the potential to emulate an individual's personality and responses and the ethical questions surrounding it [1:45:45];
    • Parting thoughts [1:50:15]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 15, 2024

    Zone 2 training: impact on longevity and mitochondrial function, how to dose frequency and duration, and more | Iñigo San-Millán, Ph.D. (#201 rebroadcast)

    Zone 2 training: impact on longevity and mitochondrial function, how to dose frequency and duration, and more | Iñigo San-Millán, Ph.D. (#201 rebroadcast)

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Iñigo San-Millán is an internationally renowned applied physiologist and a previous guest on The Drive. His research and clinical work focuses on exercise-related metabolism, metabolic health, diabetes, cancer metabolism, nutrition, sports performance, and critical care. In this episode, Iñigo describes how his work with Tour de France winner Tadej Pogačar has provided insights into the amazing potential of elite athletes from a performance and metabolic perspective. He speaks specifically about lactate levels, fat oxidation, how carbohydrates in food can affect our lactate and how equal lactate outputs between an athlete and a metabolically unhealthy individual can mean different things. Next, he discusses how Zone 2 training boosts mitochondrial function and impacts longevity. He explains the different metrics for assessing one’s Zone 2 threshold and describes the optimal dose, frequency, duration, and type of exercise for Zone 2. Additionally, he offers his thoughts on how to incorporate high intensity training (Zone 5) to optimize health, as well as the potential of metformin and NAD to boost mitochondrial health. Finally, he discusses insights he’s gathered from studying the mitochondria of long COVID patients in the ICU.

    We discuss:

    • The amazing potential of cyclist Tadej Pogačar [2:00];
    • Metrics for assessing athletic performance in cyclists and how that impacts race strategy [7:30];
    • The impact of performance-enhancing drugs and the potential for transparency into athletes’ data during competition [16:15];
    • Tadej Pogačar’s race strategy and mindset at the Tour de France [23:15];
    • Defining Zone 2, fat oxidation, and how they are measured [26:00];
    • Using fat and carbohydrate utilization to calculate the mitochondrial function and metabolic flexibility [35:00];
    • Lactate levels and fat oxidation as it relates to Zone 2 exercise [39:15];
    • How moderately active individuals should train to improve metabolic function and maximize mitochondrial performance [51:00];
    • Bioenergetics of the cell and what is different in elite athletes [56:30];
    • How the level of carbohydrate in the diet and ketogenic diets affects fuel utilization and power output during exercise [1:07:45];
    • Glutamine as a source for making glycogen—insights from studying the altered metabolism of ICU patients [1:14:15];
    • How exercise mobilizes glucose transporters—an important factor in diabetic patients [1:20:15];
    • Metrics for finding Zone 2 threshold—lactate, heart rate, and more [1:24:00];
    • Optimal Zone 2 training: dose, frequency, duration, and type of exercise [1:40:30];
    • How to incorporate high intensity training (Zone 5) to increase VO2 max and optimize fitness [1:50:30];
    • Compounding benefits of Zone 2 exercise and how we can improve metabolic health into old age [2:01:00];
    • The effects of metformin, NAD, and supplements on mitochondrial function [2:04:30];
    • The role of lactate and exercise in cancer [2:12:45];
    • How assessing metabolic parameters in long COVID patients provides insights into this disease [2:18:30];
    • The advantages of using cellular surrogates of metabolism instead of VO2 max for prescribing exercise [2:25:00];
    • Metabolomics reveals how cellular metabolism is altered in sedentary individuals [2:33:00];
    • Cellular changes in the metabolism of people with diabetes and metabolic syndrome [2:38:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 08, 2024

    #308 - AMA #61: Sun exposure, sunscreen, and skin health: relationship between sun exposure and skin cancer, vitamin D production, and photoaging, how to choose a sunscreen, and more

    #308 - AMA #61: Sun exposure, sunscreen, and skin health: relationship between sun exposure and skin cancer, vitamin D production, and photoaging, how to choose a sunscreen, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter delves into two topics that have generated a lot of questions over the years: skin cancer and sunscreen. He begins by exploring the basics of UV radiation, discussing its effects on vitamin D conversion, photoaging, and its role in skin cancer. He examines various skin types, discussing their implications for sun exposure and vitamin D levels, as well as how to determine where you fall on the skin type scale. He then delves into the various types of skin cancer, with a particular emphasis on melanoma, exploring its complex relationship with UV exposure and other contributing risk factors. Additionally, he covers tanning beds, the importance of early skin cancer detection through regular skin checks, and the often confusing topic of sunscreen. He explains how sunscreen affects UV radiation and skin cancer risk, what SPF levels to choose, the differences between organic and mineral sunscreens, and what to consider when selecting the best sunscreen for your needs.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #61 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • The impact of UV radiation on the skin [2:00];
    • Understanding solar UV: from the electromagnetic spectrum to skin health [3:45];
    • The role of sunlight in vitamin D production [8:30];
    • Factors contributing to vitamin D deficiency: insufficient UV exposure, magnesium levels, and more [9:45];
    • Sun exposure needs for different skin types, and the limitations of current studies in defining vitamin D deficiency [12:45];
    • The acute and long-term effects of excessive UV exposure: sunburn, photoaging, and the increased risk of skin cancer [15:30];
    • Types of skin cancer and associations with UV exposure [17:45];
    • The complex relationship between melanoma and UV exposure [22:15];
    • Why UV exposure alone doesn’t necessarily explain the risk for melanoma [25:15];
    • Other risk factors for melanoma [29:15];
    • Tanning beds and skin cancer risk [34:45];
    • Balancing sun exposure: benefits and risks [38:15];
    • Tattoos and sun exposure [40:30];
    • The importance of regular skin checks, dermatologists, and emerging technologies showing promise for early detection of cancer [41:45];
    • Self-skin checks: what to look for [46:30];
    • Prevalence of skin cancer and the importance of early detection [49:30];
    • Summary of the major risk factors for melanoma [54:15];
    • The role of sunscreen in reducing skin cancer risk [55:45];
    • How sunscreen works, the differences between chemical and mineral sunscreens, an explanation of SPF, and more [58:30];
    • How to determine the appropriate sunscreen SPF to use based on the UV index [1:04:45];
    • Choosing the right sunscreen for your individual needs [1:07:00];
    • The impact of water and perspiration on sunscreen effectiveness [1:12:00];
    • Chemical vs. mineral sunscreens: safety concerns and recommendations [1:14:00];
    • Concerns about hormone effects from chemical sunscreens [1:19:15];
    • Sunscreen summary: skin types, key considerations, recommended brands, and more [1:23:15]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJuly 01, 2024

    #307 ‒ Exercise for aging people: where to begin, and how to minimize risk while maximizing potential | Peter Attia, M.D.

    #307 ‒ Exercise for aging people: where to begin, and how to minimize risk while maximizing potential | Peter Attia, M.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this special episode, Peter addresses the common questions about starting or returning to an exercise routine over the age of 50. Individuals in this age group have frequently reached out with questions about whether it's too late to start exercising and often express concern over a lack of prior training, a fear of injury, or uncertainty about where to begin. Peter delves into the importance of fitness for older adults, examining all four pillars of exercise, and provides practical advice on how to start exercising safely, minimize injury risk, and maximize potential benefits. Although this conversation focuses on people in the “older” age category, it also applies to anyone of any age who is deconditioned and looking to ease into regular exercise.

    We discuss:

    • Key points about starting exercise as an older adult [2:45];
    • Why it’s never too late to begin exercising and incorporating the four pillars of exercise [5:45];
    • The gradual, then sharp, decline in muscle mass and activity level that occur with age [10:00];
    • The decline of VO2 max that occurs with age [15:30];
    • Starting a training program: exercise variability, movement quality, realistic goals, and more [18:30];
    • Improving aerobic capacity: the malleability of the system, the importance of consistency, and setting long-term fitness goals [25:15];
    • Starting cardio training: base building, starting with low volume, and zone 2 training [30:45];
    • The critical role of VO2 max in longevity [36:45];
    • How to introduce VO2 max training to older or deconditioned individuals [46:15];
    • Options for performing zone 2 and VO2 max training [53:45];
    • The ability to make gains in strength and muscle mass as we age [57:00];
    • How to implement strength training for older individuals [1:01:00];
    • Advice for avoiding injury when strength training [1:07:30];
    • Risk of falls: the devastating consequences and the factors that increase fall risk [1:12:15];
    • Mitigating fall risk: the importance of foot and lower leg strength, ankle mobility, and balance [1:19:45];
    • Improving bone mineral density through resistance training [1:24:30];
    • The importance of protein in stimulating muscle protein synthesis, especially in older adults [1:31:00];
    • Parting advice from Peter [1:34:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 24, 2024

    #306 - AMA #60: preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

    #306 - AMA #60: preventing cognitive decline, nutrition myths, lowering blood glucose, apoB, and blood pressure, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this “Ask Me Anything” (AMA) episode, Peter provides insights on a broad range of important topics. He delves into the prevention of cognitive decline, the link between cardiovascular disease and Alzheimer's disease, and methods to lower blood glucose, insulin, and apoB. He also addresses nutrition-related queries, exploring the impact of dietary habits on weight loss and longevity, how a person can identify the best diet for themselves, and common nutrition myths. Additional discussions include optimal blood pressure, daily step goals, the benefits of standing versus sitting desks, and much more.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #60 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Overview of topics and episode format [1:40];
    • Preventing cognitive decline [5:00];
    • How to lower blood glucose and insulin [13:30];
    • The relationship between lipids, CVD, and Alzheimer’s disease, and whether statins can increase the risk of neurodegenerative disorders and AD [23:15];
    • Reducing apoB levels through exercise and diet [31:45];
    • Pharmacological options for lowering apoB [38:00];
    • How nutrition impacts longevity via metabolic health, muscle mass, BMD and more [40:15];
    • How can someone determine the best diet for themselves? [43:45];
    • Nutrition myth: All weight loss is good [46:45];
    • Nutrition myth: Metabolic rates are dramatically different among individuals based on genetics [49:00];
    • Nutrition myth: Losing weight after a brief period of overeating is impossible [53:45];
    • Nutrition myth: GLP-1 agonists are a replacement for a healthy lifestyle [57:45];
    • Nutrition myth: There is a single best diet for weight loss [1:03:00];
    • Nutrition oversimplification: All calories are created equal [1:05:45];
    • Daily step goals [1:06:45];
    • The benefits of standing versus sitting throughout the day [1:10:45];
    • How to identify the most impactful and easiest-to-implement ways to improve your health [1:12:30];
    • The critical importance of emotional health [1:14:30];
    • Why supplements should be considered as supportive aids rather than primary solutions in one’s strategy to improve longevity [1:18:00];
    • Strategies for reducing high blood pressure [1:20:45];
    • Peter’s biggest frustrations with "mainstream health advice" [1:28:00];
    • Peter’s chaotic, yet cherished, morning routine [1:31:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 17, 2024

    #305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson

    #305 ‒ Heart rate variability: how to measure, interpret, and utilize HRV for training and health optimization | Joel Jamieson

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Joel Jamieson is a conditioning expert who developed Morpheus to give people a smarter way to build their conditioning regimen and improve their recovery. In this episode, Joel dives deep into the world of heart rate variability (HRV), explaining its scientific foundation, how it measures the balance between the sympathetic and parasympathetic nervous systems, the various methods of measurement, and how it can guide healthier lifestyle choices and improved training performance. He explores the nuances of HRV calculation, the impact of aging on HRV, and the roles of genetics, exercise, and other lifestyle factors in this process. He also covers Morpheus, the innovative training tool that won Peter over after his initial skepticism, highlighting its practicality and effectiveness in guiding training and optimizing fitness outcomes.

    We discuss:

    • Heart rate variability (HRV): evolution, science, and practical applications of HRV in athletic training [4:00];
    • Methods of measuring HRV: EKG, wrist-based sensors, and more [11:30];
    • How HRV is calculated from the data [22:30];
    • The role of the autonomic nervous system (ANS) in regulating HRV [25:45];
    • The decline in HRV with age, and the mitigating effects of fitness and other lifestyle factors [33:30];
    • The role of genetics in HRV, the modifiability of HRV, and a comparison of VO2 max and HRV as predictors of mortality [37:00];
    • How aging affects HRV and sympathetic drive, and the importance of spontaneous movement and exercise in maintaining the body's adaptability [43:30];
    • How Morpheus measures HRV using RMSSD and normalizes it to a 100-point scale for easier interpretation [49:45];
    • The Morpheus system: development, integration with various metrics, and personalized daily training recommendations to optimize fitness and recovery [51:30];
    • The benefits of morning HRV readings for assessing daily readiness compared to overnight HRV measurements [1:03:00];
    • Why Morpheus recommends using a chest strap rather than an arm band [1:10:00];
    • The impact of consistent exercise, stress, alcohol, and other lifestyle factors on HRV [1:11:15];
    • Optimizing zone 2 training with Morpheus [1:18:15];
    • Using heart rate recovery (HRR) as an indicator of athletic conditioning and the balance between aerobic and anaerobic systems [1:22:45];
    • The importance of tracking HRV trends over time rather than focusing on data from a given day [1:29:00];
    • Effect of GLP-1 agonists on heart rate and HRV [1:34:45];
    • Where HRV belongs in the hierarchy of health metrics [1:42:00];
    • Parting thoughts [1:46:30]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 10, 2024

    #304 – NEW: Introducing quarterly podcast summaries - Peter shares his biggest takeaways on muscle protein synthesis, VO2 max, toe strength, gut health, and more

    #304 – NEW: Introducing quarterly podcast summaries - Peter shares his biggest takeaways on muscle protein synthesis, VO2 max, toe strength, gut health, and more

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    In this quarterly podcast summary (QPS) episode, Peter introduces a new format aimed at summarizing his biggest takeaways from the last three months of guest interviews on the podcast. Peter shares key insights from each episode, covering diverse topics such as protein and muscle building with Luc van Loon, toe strength with Courtney Conley, VO2 max with Olav Aleksander Bu, liquid biopsies for cancer with Alex Aravanis, gut health and probiotics with Colleen Cutcliffe, and road safety with Mark Rosekind. Additionally, Peter shares any personal behavioral adjustments or modifications to his patient care practices that have arisen from these engaging discussions.

    If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the episode #304 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • How Peter keeps track of his takeaways from each podcast episode [5:15];
    • Luc van Loon episode: fat utilization, muscle protein synthesis, dietary protein, aging and inactivity, and more [8:45];
    • Behavioral changes that have come about from the conversation with Luc van Loon [23:45];
    • Courtney Conley episode: importance of toe strength and the impact of dedicated foot training [26:45];
    • Olav Aleksander Bu episode: the importance of VO2 max for lifespan, and the practicalities of measuring and improving VO2 max [36:45];
    • Behavioral changes that have come about from the conversation with Olav [56:00];
    • Alex Aravanis episode: liquid biopsies for cancer detection [1:01:30];
    • Colleen Cutcliffe episode: the importance of gut bacteria balance, and the potential therapeutic uses of probiotics, particularly Akkermansia [1:16:45];
    • Mark Rosekind: the significant issue of road fatalities and injuries, their causes, and practical safety measures to reduce risks [1:27:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enJune 03, 2024

    #303 - A breakthrough in Alzheimer’s disease: the promising potential of klotho for brain health, cognitive decline, and as a therapeutic tool for Alzheimer's disease | Dena Dubal, M.D., Ph.D.

    #303 - A breakthrough in Alzheimer’s disease: the promising potential of klotho for brain health, cognitive decline, and as a therapeutic tool for Alzheimer's disease | Dena Dubal, M.D., Ph.D.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Dena Dubal is a physician-scientist and professor of neurology at UCSF whose work focuses on mechanisms of longevity and brain resilience. In this episode, Dena delves into the intricacies of the longevity factor klotho: its formation and distribution in the body, the factors such as stress and exercise that impact its levels, and its profound impact on cognitive function and overall brain health. Dena shares insights from exciting research in animal models showing the potential of klotho in treating neurodegenerative diseases as well as its broader implications for organ health and disease prevention. She concludes with an optimistic outlook for future research in humans and the potential of klotho for the prevention and treatment of Alzheimer’s disease.

    Disclosure: Peter is an investor in Jocasta Neuroscience, a company working to develop klotho as a therapy for people with Alzheimer’s disease.

    We discuss:

    • Dena’s fascination with aging and how she came to study klotho [3:30];
    • Biological properties of klotho: production, regulation, decline with age, and factors influencing its levels [11:45];
    • Potential benefits of klotho on brain health [22:00];
    • The relationship between soluble klotho protein, platelet factors, and cognitive enhancement [33:45];
    • The role of platelet factor 4 (PF4) and it’s interaction with GluN2B in mediating cognitive enhancement [46:45];
    • Benefits of klotho observed in a mouse model of Parkinson’s disease [55:45];
    • Benefits of klotho observed in a mouse model of Alzheimer’s disease [1:03:00];
    • Promising results of klotho in primate models, and the importance of finding an appropriate therapeutic dose before moving to human trials [1:08:00];
    • Speculating why a single klotho injection has such long-lasting effects [1:25:30];
    • Potential cognitive benefits of klotho in humans, the impact of the KL-VS genetic variant on klotho levels, and the need for human trials to confirm these effects [1:27:45];
    • The interaction between the KL-VS genetic variant and APOE4 and how it impacts risk of Alzheimer’s disease [1:34:45];
    • The significance of klotho levels: studies linking lower levels to increased mortality and the broader implications for organ health and disease prevention [1:47:15];
    • Measuring klotho levels and determining an individual’s KL-VS status [1:52:15];
    • The promising potential of klotho for Alzheimer’s disease treatment, and the importance of philanthropy for funding research [1:58:00]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 27, 2024

    #302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

    #302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter’s Weekly Newsletter

    Julia Wattacheril is a physician scientist and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. In this episode, Julia delves deep into the complex world of liver health, beginning with a foundational overview of liver physiology. She provides an in-depth look at how alcohol impacts liver function, breaking down the metabolism of ethanol and its detrimental effects. Julia then shifts the focus to understanding liver function tests and optimal enzyme levels, providing a detailed explanation of AST and ALT and elucidating why fluctuations in these levels may or may not be concerning. She provides a primer on the four major stages of liver disease, discussing risk and emphasizing the importance of early diagnosis. Julia highlights the role of liver disease in increasing the risk of cancer and cardiovascular disease and covers in detail the various strategies for diagnosing, treating, and preventing the progression of liver disease.

    We discuss:

    • Julia’s training, the importance of liver health, and the challenges and innovations of hepatology [3:15];
    • The complex and crucial functionality of the liver, its four most essential functions, and more [8:45];
    • Liver injuries: historical and evolving understanding of causal factors, and the progression to liver diseases and cancer [13:15];
    • How the liver metabolizes nutrients and what happens in the presence of excess calories or alcohol [24:45];
    • Methods of diagnosing liver disease and how insights guide treatment and management strategies [33:30];
    • The poisonous nature of ethanol to the liver [40:30];
    • Varied responses to alcohol, damaging effects of alcohol beyond the liver, and the process of advising patients on their alcohol consumption [47:15];
    • Understanding liver enzymes AST and ALT—interpreting levels, lifestyle factors that affect them, and diagnostic approaches [58:30];
    • Interpreting liver function tests for fatty liver disease, and the challenges of diagnosing liver pathologies, particularly in children versus adults [1:13:15];
    • Comprehensive liver health assessments via imaging and various diagnostic tools to prevent overlooking potential liver pathologies [1:18:45];
    • Potential impact of recreational drugs, statins, and other medications on liver function test results [1:26:45];
    • Shifting nomenclature from NAFLD to MASLD to reflect accuracy in the underlying pathophysiology and understanding of liver diseases [1:30:30];
    • Pathophysiology of MASLD, the need for proactive screening, and the significance of liver fat percentage as an indicator of metabolic health [1:36:30];
    • The importance of screening for rare conditions alongside common metabolic diseases associated with fatty liver accumulation [1:42:45];
    • Practical strategies for managing MAFLD [1:45:30];
    • The impact of fructose consumption on liver health and the challenges of disentangling its effects from other factors like obesity and insulin resistance [1:52:45];
    • The potential of GLP-1 agonists for the treatment of MASLD [1:57:45];
    • How the four stages of liver disease have evolved [2:00:30];
    • Increased cancer and heart disease risk associated with early-stage MAFLD [2:05:15];
    • Emerging drugs and therapies for addressing fat accumulation and fibrosis related to MAFLD [2:12:15];
    • Peter’s major takeaways [2:18:45]; and
    • More.

    Connect With Peter on TwitterInstagramFacebook and YouTube

    The Peter Attia Drive
    enMay 20, 2024

    Related Episodes

    Episode 96- Combining Genetics, Lab Testing and Personalized Nutrition to Finally Heal with Dr. Mike Mallin

    Episode 96- Combining Genetics, Lab Testing and Personalized Nutrition to Finally Heal with Dr. Mike Mallin

    Today we welcome guest Dr. Mike Mallin. Dr. Mallin started the company Wild Health in hopes to transform the ways of modern day medicine. Here, the team at Wild Health combine genomics and blood testing to find the root causes of many stubborn health issues. They personally work with individuals to heal the body through food and supplement specific recommendations. 

    This week we discuss:

    [3:22]- We are two weeks away from the launch of my online reversing insulin resistance course, Finding Nutritional PEACE. It launches on OCT 3, and registration is now open HERE! 

    [4:50]- I am hosting three FREE master classes for you to learn more about Finding Nutritional PEACE! Register for 3 Little Known Secrets to Effortlessly Manage Your Weight and Bloodsugar HERE. 

    [8:32]- Personalized protocols have been one of my most highly requested services lately, and I have received wonderful feedback about them! More information on this service HERE. 

    [10:43]- How Dr. Mallin left the conventional medical system and transformed his teachings

    [17:32]- The services Dr. Mallin offers and what it is like to work with him

    [24:28]- What it means to be metabolically flexible

    [27:51]- Dr. Mallin’s views on time restricted eating and fasting

    [34:30]- The correlation between insulin resistance and blood pressure and how healing insulin resistance positively changes blood pressure

    [41:28]- What is the one thing Dr. Mallin would like people to know more about nutrition?

    [48:00]- Tips for parents to help prevent insulin resistance amongst their children and type 2 diabetes 

    [54:08]- Find Wild Health HERE and the different programs they offer! 

    FOR MORE INFORMATION FROM DR. MALLIN:

    Dr. Mallin's Podcast: Wild Health Podcast

    Wild Health Website: Wild Health 

    FOLLOW ME ON:

    Instagram: @shana.hussin.rdn

    Facebook: Fast To Heal With Shana Hussin

    Website: https://www.fasttoheal.info/

    ADDITIONAL LINKS:

    ENROLL in my FREE Masterclass, 3 Little Known Secrets to Effortlessly Manage Your Weight and Blood Sugar.

    ENROLL IN FAST TRACK, my new monthly membership program for onging learning, support, and accountability.

    GRAB YOUR COPY of the Fast To Heal Recipe book with 85 low-carb, whole food recipes that are simple to prepare!

    GET YOUR FREE STARTING GUIDES that will set you well on your way toward a low-carb lifestyle of timed eating!

    SCHEDULE A PERSONALIZED SESSION if you are stuck in a rut, or suffer from a stubborn case of obesity, Type 2 diabetes, or metabolic illness.

    JUMPSTART your fasting and low-carb protocol by enrolling in my 10-Day Hormone Healing Jumpstart!

    ENROLL in Metabolic Makeover, my STARTER COURSE to find your fasting method, implement therapeutic carb restriction, and learn how to bust through weight and health stalls.

    Is Ozempic a Weight Loss Miracle?

    Is Ozempic a Weight Loss Miracle?

    Unless you’ve been living off-grid for the last few months, chances are you’ve heard of Ozempic (or semaglutide)– the newest FDA approved miracle injection for weight loss. Social media has ignited feeds across the world with weight loss transformation posts from semaglutide injections- and 812 million views on TikTok to be exact.

    Tailored to diabetes, this drug works by stimulating insulin secretion and therefore lowering fasting and postprandial glucose levels in four mechanisms. During the Ozempic drug trials, it was noted that weight loss was such a consistent and dramatic side effect that the FDA approved semaglutide for weight loss under the brand name Wegovy in 2021.

    In this episode, I discuss:

    • The four mechanisms of Ozempic
      •  Changes in insulin sensitivity
      • Increased energy expenditure by encouraging stored fat to turn into energy.
      • Slows gastric emptying
      • The impact on appetite.
    • And what current research is finding. (Hint: It might not be a long-term weight loss miracle!)

    To sum it up, weight loss medications like Ozempic cannot have substantial results without compromise (i.e. losing lean muscle mass). Most importantly, NONE of the weight loss medications are fixing the root cause of the problem. The purpose of this podcast is to help you make an informed decision about your options for weight loss. If you are considering semaglutide injections for weight loss, talk to your doctor about the pros and cons!

    Love it? Hate it? We’d love to hear your feedback!

     

    References used for this episode:  

    1.    https://pubmed.ncbi.nlm.nih.gov/30122305/

    O'Neil PM, Birkenfeld AL, McGowan B, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018;392(10148):637-649. doi:10.1016/S0140-6736(18)31773-2

    2.   https://pubmed.ncbi.nlm.nih.gov/33755728/ 

    Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.322

    3.   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769337/ 

    Sargeant JA, Henson J, King JA, Yates T, Khunti K, Davies MJ. A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans. Endocrinol Metab (Seoul). 2019 Sep;34(3):247-262. doi: 10.3803/EnM.2019.34.3.247. PMID: 31565876; PMCID: PMC6769337.

    4.  https://pubmed.ncbi.nlm.nih.gov/35441470/ 

    Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. doi:10.1111/dom.14725

     

    Interested in our Lean for Life Membership?

    Help yourself feel aligned using our three phase approach: Lean for Life Membership called Heal, Optimize , and Refinewhere you will be empowered to reverse previous metabolic damage with the assistance of our team of Registered Dietitian Nutritionists. Check out more details on our website!

    Want to learn more about our one-on-one Empowered Nutrition coaching? Book a free chemistry call to discuss your story and see if we're a good fit.

    Enjoying the podcast?

    Please review the Empowered Nutrition Podcast on Apple Podcasts or wherever you listen! Then, send me a screenshot of your positive review to podcast@empowerednutrition.health as a DM on Instagram (@empowerednutrition.health).Include a brief description of what you’re working on with your health and/or nutrition and I’ll send you a free custom meal plan!

    Do you have questions you would like answered on the Empowered Nutrition podcast? You can propose your questions/ideas here or reach out to me at podcast@empowerednutrition.health

    Follow us on:

    Facebook | Instagram | Pinterest

     

     

     

     

    EP 3: Let's Go!

    EP 3: Let's Go!
    Alright, so you've got everything together, you've listened to the other episodes and you're ready to start, pen is in hand...

    Let's do this! :)

    In this episode, I'll go over in details my best practices for starting out as a total beginner to all things fasting, lots of tips and advice to what is most important when you start to integrate this tool into your lifestyle and how it can make the difference between success or frustration. 

    >>For supportive coaching help from me, please visit: TheFastingFocusedLifestyle.com

    The Genetics of Obesity

    The Genetics of Obesity
    Genetics and the brain play a key role in predisposing some people to obesity. In this Cambridge podcast Catherine Carr looks at how biochemists and neuroscientists are working together to discover the triggers to weight gain. Professor Stephen O'Rahilly of the Institute of Metabolic Science at Cambridge University describes how key genes can contribute to severe cases of obesity, while Dr Sadaf Farooqi a Senior Clinical Fellow at the University, recalls the eureka moment of singling out the first gene to be directly linked with obesity. Psychiatrist Paul Fletcher meanwhile, considers how genetics can directly affect our feelings and behaviours around food. Image credit: FightObesity from Flickr

    The Secret to the Happy Healthy Guys

    The Secret to the Happy Healthy Guys

    It’s not every day you get to meet real super heroes. Dr. Rob Vasquez and Dr. Randall Johns sat down with me for a candid interview to share a little bit of their health challenges and how it changed the direction of their lives. Both of them were poster boys for success, health and fitness and at different times had both experienced life changing health challenges. Check out how these two gentlemen turned their personal tragedies into their biggest vision to serve and have a positive impact on others. Join me with The Secret of the Happy Healthy Guys.

    HappyHealthyCentral.com
    sctoil.com Developers of SCT Oil